Connecting and Leveraging Quality-Driven Data Throughout the Pharmaceutical Product Life Cycle
View web version.
Reduce Time-to-market and OOS using AQbD

Symposium Agenda

  • Session 1: Regulatory changes in Analytical Development
  • Session 2: AQbD Enhanced Method development
  • Session 3: OOS Reduction In QC Labs using QbD and Quality Risk Management
  • Session 4: Forced Degradation studies: the role of AQbD and Exact Mass

Speakers

  • Horacio Pappa, USP
  • Stephen Maddocks, MHRA
  • Ilse Hoes, Waters
  • Lilia Sghaier & Maxime Lille, Minakem
  • Szabolcs Fekete, Waters
  • Gérald de Fontenay, Cebiphar
  • Tracy Hibbs, Waters
  • Pauline McGregor, PMcG consulting
  • Joe Turpin, S-Matrix
  • Amanda Guiraldelli, USP
  • Chris Henry, Waters
Register Now
 
This email was sent by: %%Member_Busname%%
%%Member_Addr%%, %%Member_City%%, %%Member_State%%, %%Member_PostalCode%% %%Member_Country%%


Privacy Policy

Update Profile      Manage Subscriptions      Unsubscribe